A carregar...
Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsis
INTRODUCTION: Kallistatin levels in the circulation are reduced in patients with sepsis and liver disease. Transgenic mice expressing kallistatin are resistant to lipopolysaccharide (LPS)-induced mortality. Here, we investigated the effect of kallistatin on survival and organ damage in mouse models...
Na minha lista:
| Publicado no: | Crit Care |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4445990/ https://ncbi.nlm.nih.gov/pubmed/25930108 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-015-0919-4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|